>
Switch to:

Corcept Therapeutics PS Ratio

: 7.90 (As of Today)
View and export this data going back to 2004. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Corcept Therapeutics's share price is $22.530000. Corcept Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $2.85. Hence, Corcept Therapeutics's PS Ratio for today is 7.90.

NAS:CORT' s PS Ratio Range Over the Past 10 Years
Min: 3.74   Med: 11.64   Max: 449
Current: 7.91

3.74
449

During the past 13 years, Corcept Therapeutics's highest PS Ratio was 449.00. The lowest was 3.74. And the median was 11.64.

NAS:CORT's PS Ratio is ranked higher than
71% of the 946 Companies
in the Biotechnology industry.

( Industry Median: 20.82 vs. NAS:CORT: 7.91 )

Corcept Therapeutics's Revenue per Sharefor the three months ended in Dec. 2020 was $0.68. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $2.85.

Warning Sign:

Corcept Therapeutics Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Corcept Therapeutics was 13.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 30.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 46.10% per year.

During the past 13 years, Corcept Therapeutics's highest 3-Year average Revenue per Share Growth Rate was 230.20% per year. The lowest was -100.00% per year. And the median was 57.25% per year.

Back to Basics: PS Ratio


Corcept Therapeutics PS Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.31 14.18 6.73 4.84 9.17

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 4.34 5.87 6.02 9.17

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Corcept Therapeutics PS Ratio Distribution

* The bar in red indicates where Corcept Therapeutics's PS Ratio falls into.



Corcept Therapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Corcept Therapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=22.530000/2.852
=7.90

Corcept Therapeutics's Share Price of today is $22.530000.
Corcept Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.763 (Mar. 2020 ) + 0.719 (Jun. 2020 ) + 0.694 (Sep. 2020 ) + 0.676 (Dec. 2020 ) = $2.85.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Corcept Therapeutics  (NAS:CORT) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Corcept Therapeutics PS Ratio Related Terms


Corcept Therapeutics PS Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)